![(±)-4-[2-[[3-(4-hydroxyphenyl)-1-methylpropyl]amino]-1-hydroxyethyl]phenol hydrochloride PAYLEAN; RACTOPAMINE HYDROCHLORIDE 604-068-00-8 structure](https://www.ebi.ac.uk/opsin/ws/(%C2%B1)-4-%5B2-%5B%5B3-(4-hydroxyphenyl)-1-methylpropyl%5Damino%5D-1-hydroxyethyl%5Dphenol%20hydrochloride%20PAYLEAN%3B%20RACTOPAMINE%20HYDROCHLORIDE%20604-068-00-8.png)
(±)-4-[2-[[3-(4-hydroxyphenyl)-1-methylpropyl]amino]-1-hydroxyethyl]phenol hydrochloride PAYLEAN; RACTOPAMINE HYDROCHLORIDE 604-068-00-8
Name
(±)-4-[2-[[3-(4-hydroxyphenyl)-1-methylpropyl]amino]-1-hydroxyethyl]phenol hydrochloride PAYLEAN; RACTOPAMINE HYDROCHLORIDE 604-068-00-8
Molecular Formula
C18H24ClNO3
Identifiers
cas number 90274-24-1 PRIMARY
ec number 415-170-5
chemical name Ractopamine hydrochloride
chemical name (±)-4-[2-[[3-(4-hydroxyphenyl)-1-methylpropyl]amino]-1-hydroxyethyl]phenol hydrochloride PAYLEAN; RACTOPAMINE HYDROCHLORIDE 604-068-00-8
GHS Hazard Pictograms
GHS07 Hazard Classifications
Acute Tox. 4
Warning
Acute toxicity (oral + dermal + inhalation)
Hazard Code: H302 + H312 + H332
Category: Acute Tox. 4
Source: Harmonised C&L
Skin Sens. 1
Warning
Skin sensitisation
Hazard Code: H317
Category: Skin Sens. 1
Source: Harmonised C&L
Regulatory Lists (1)
KEMI PRIO PHASE-OUT SUBSTANCES
KEMI PRIO Phase-Out Substances — Swedish Chemicals Agency list of substances with properties of very high concern that should be phased out
Disclaimer
The substance data provided is sourced from various third-party databases and regulatory sources. While we strive to maintain accuracy, we cannot guarantee the completeness, accuracy, or timeliness of this information. Users are responsible for verifying all data before use in compliance, safety, or regulatory contexts. NextSDS is not liable for any decisions made based on this data.